# FDA Inspection 1105851 - Evonik Rexim S.A.S. - September 06, 2019

Source: https://www.keypedia.com/records/fda_inspections/evonik-rexim-sas/a84788ab-dd56-42d8-9791-da6ef5e7c53f
Source feed: FDA_Inspections

> FDA Inspection 1105851 for Evonik Rexim S.A.S. on September 06, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1105851
- Company Name: Evonik Rexim S.A.S.
- Inspection Date: 2019-09-06
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1275961 - 2024-03-28](https://www.keypedia.com/records/fda_inspections/evonik-rexim-sas/a1d59a43-54fe-4cda-a999-27f07d8cf639)
- [FDA Inspection 990167 - 2016-09-16](https://www.keypedia.com/records/fda_inspections/evonik-rexim-sas/60ab9007-dfda-4296-94a8-664c193cb77d)
- [FDA Inspection 754360 - 2011-10-13](https://www.keypedia.com/records/fda_inspections/evonik-rexim-sas/a0c4f944-b9e9-47d6-a3f2-f02be17a4031)

Company: https://www.keypedia.com/companies/evonik-rexim-sas/562e2bfa-9c00-490f-ae81-8fe3f59fe78a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c